Immunology by numbers: Quantitation of antigen presentation completes the quantitative milieu of systems immunology!

Current Opinion in Immunology

Volumn 40, Issue , 2016, Pages 88-95

  Purcell, Anthony W ^a   Croft, Nathan P ^a   Tscharke, David C ^b  

^a MONASH UNIVERSITY   (Australia)

^b Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; ANTIGEN; HISTOCOMPATIBILITY ANTIGEN; MULTIPROTEIN COMPLEX; PEPTIDE;

ANTIGEN PRESENTATION; CROSS REACTION; FLOW CYTOMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; REVIEW; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; ANIMAL; CELL SEPARATION; METABOLISM; SYSTEMS BIOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL SEPARATION; CROSS REACTIONS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MASS SPECTROMETRY; MULTIPROTEIN COMPLEXES; PEPTIDES; SYSTEMS BIOLOGY;

EID: 84962348913     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.03.007     Document Type: Review

References (59)

1. Croft N.P., Smith S.A., Wong Y.C., Tan C.T., Dudek N.L., Flesch I.E., Lin L.C., Tscharke D.C., Purcell A.W. Kinetics of antigen expression and epitope presentation during virus infection. PLOS Pathog 2013, 9:e1003129.
2. Addona T.A., Abbatiello S.E., Schilling B., Skates S.J., Mani D.R., Bunk D.M., Spiegelman C.H., Zimmerman L.J., Ham A.J., Keshishian H., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009, 27:633-641.
3. Canaday D.H. Production of CD4(+) and CD8(+) T cell hybridomas. Methods Mol Biol 2013, 960:297-307.
4. Sanderson S., Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 1994, 6:369-376.
5. Karttunen J., Sanderson S., Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 1992, 89:6020-6024.
6. Chen W., Anton L.C., Bennink J.R., Yewdell J.W. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 2000, 12:83-93.
7. Pamer E.G. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J Immunol 1994, 152:686-694.
8. Zanker D., Waithman J., Yewdell J.W., Chen W. Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses. J Immunol 2013, 191:52-59.
9. Dolan B.P. Quantitating MHC class I ligand production and presentation using TCR-like antibodies. Methods Mol Biol 2013, 960:169-177.
10. Velazquez C., DiPaolo R., Unanue E.R. Quantitation of lysozyme peptides bound to class II MHC molecules indicates very large differences in levels of presentation. J Immunol 2001, 166:5488-5494.
11. Denkberg G., Cohen C.J., Lev A., Chames P., Hoogenboom H.R., Reiter Y. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC-restricted T cell receptor-like specificity. Proc Natl Acad Sci U S A 2002, 99:9421-9426.
12. Princiotta M.F., Finzi D., Qian S.B., Gibbs J., Schuchmann S., Buttgereit F., Bennink J.R., Yewdell J.W. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003, 18:343-354.
13. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., Germain R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997, 6:715-726.
14. Andersen P.S., Stryhn A., Hansen B.E., Fugger L., Engberg J., Buus S. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc the Natl Acad Sci U S A 1996, 93:1820-1824.
15. Cohen C.J., Denkberg G., Lev A., Epel M., Reiter Y. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions. J Mol Recognit 2003, 16:324-332.
16. Cohen C.J., Sarig O., Yamano Y., Tomaru U., Jacobson S., Reiter Y. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies. J Immunol 2003, 170:4349-4361.
17. Cohen C.J., Hoffmann N., Farago M., Hoogenboom H.R., Eisenbach L., Reiter Y. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Res 2002, 62:5835-5844.
18. Medina F., Ramos M., Iborra S., de Leon P., Rodriguez-Castro M., Del Val M. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo. J Immunol 2009, 183:4639-4647.
19. Neethling F.A., Ramakrishna V., Keler T., Buchli R., Woodburn T., Weidanz J.A. Assessing vaccine potency using TCR mimic antibodies. Vaccine 2008, 26:3092-3102.
20. Verma B., Neethling F.A., Caseltine S., Fabrizio G., Largo S., Duty J.A., Tabaczewski P., Weidanz J.A. TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models. J Immunol 2010, 184:2156-2165.
21. Weidanz J.A., Piazza P., Hickman-Miller H., Woodburn D., Nguyen T., Wahl A., Neethling F., Chiriva-Internati M., Rinaldo C.R., Hildebrand W.H. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods 2007, 318:47-58.
22. Sim A.C., Too C.T., Oo M.Z., Lai J., Eio M.Y., Song Z., Srinivasan N., Tan D.A., Pang S.W., Gan S.U., et al. Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies. Sci Rep 2013, 3:3232.
23. Makler O., Oved K., Netzer N., Wolf D., Reiter Y. Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity. Eur J Immunol 2010, 40:1552-1565.
24. Bossi G., Gerry A.B., Paston S.J., Sutton D.H., Hassan N.J., Jakobsen B.K. Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells. Oncoimmunology 2013, 2:e26840.
25. Walseng E., Walchli S., Fallang L.E., Yang W., Vefferstad A., Areffard A., Olweus J. Soluble T-cell receptors produced in human cells for targeted delivery. PLOS ONE 2015, 10:e0119559.
26. Liddy N., Bossi G., Adams K.J., Lissina A., Mahon T.M., Hassan N.J., Gavarret J., Bianchi F.C., Pumphrey N.J., Ladell K., et al. Monoclonal TCR-redirected tumor cell killing. Nat Med 2012, 18:980-987.
27. Li Y., Moysey R., Molloy P.E., Vuidepot A.L., Mahon T., Baston E., Dunn S., Liddy N., Jacob J., Jakobsen B.K., et al. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol 2005, 23:349-354.
28. Zhu X., Belmont H.J., Price-Schiavi S., Liu B., Lee H.I., Fernandez M., Wong R.L., Builes J., Rhode P.R., Wong H.C. Visualization of p53(264-272)/HLA-A*0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor. J Immunol 2006, 176:3223-3232.
29. Dudek N.L., Croft N.P., Schittenhelm R.B., Ramarathinam S.H., Purcell A.W. A systems approach to understand antigen presentation and the immune response. Methods Mol Biol 2016, 1394:189-209.
30. Henderson R.A., Cox A.L., Sakaguchi K., Appella E., Shabanowitz J., Hunt D.F., Engelhard V.H. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc Natl Acad Sci U S A 1993, 90:10275-10279.
31. Wang W., Gulden P.H., Pierce R.A., Shabanowitz J., Man S.T., Hunt D.F., Engelhard V.H., Shabanowitz J.A. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity [published erratum appears in J Immunol 1999 Mar 1;162(5):3106]. J Immunol 1997, 158:5797-5804.
32. Ternette N., Block P.D., Sanchez-Bernabeu A., Borthwick N., Pappalardo E., Abdul-Jawad S., Ondondo B., Charles P.D., Dorrell L., Kessler B.M., et al. Early kinetics of the HLA class I-associated peptidome of MVA.HIVconsv-infected cells. J Virol 2015, 89:5760-5771.
33. Lippolis J.D., White F.M., Marto J.A., Luckey C.J., Bullock T.N., Shabanowitz J., Hunt D.F., Engelhard V.H. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol 2002, 169:5089-5097.
34. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003, 100:6940-6945.
35. Chahrour O., Cobice D., Malone J. Stable isotope labelling methods in mass spectrometry-based quantitative proteomics. J Pharm Biomed Anal 2015, 113:2-20.
36. Tan C.T., Croft N.P., Dudek N.L., Williamson N.A., Purcell A.W. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 2011, 11:2336-2340.
37. Croft N.P., Purcell A.W., Tscharke D.C. Quantifying epitope presentation using mass spectrometry. Mol Immunol 2015, 68:77-80.
38. Bozzacco L., Yu H., Zebroski H.A., Dengjel J., Deng H., Mojsov S., Steinman R.M. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 2011, 10:5016-5030.
39. Lange V., Picotti P., Domon B., Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008, 4:222.
40. Picotti P., Rinner O., Stallmach R., Dautel F., Farrah T., Domon B., Wenschuh H., Aebersold R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010, 7:43-46.
41. Hogan K.T., Sutton J.N., Chu K.U., Busby J.A., Shabanowitz J., Hunt D.F., Slingluff C.L. Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members. Cancer Immunol Immunother 2005, 54:359-371.
42. Dudek N.L., Tan C.T., Gorasia D.G., Croft N.P., Illing P.T., Purcell A.W. Constitutive and inflammatory immunopeptidome of pancreatic beta-cells. Diabetes 2012, 61:3018-3025.
43. Schittenhelm R.B., Sian T.C., Wilmann P.G., Dudek N.L., Purcell A.W. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheumatol 2015, 67:702-713.
44. Hassan C., Kester M.G., Oudgenoeg G., de Ru A.H., Janssen G.M., Drijfhout J.W., Spaapen R.M., Jimenez C.R., Heemskerk M.H., Falkenburg J.H., et al. Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes. J Proteomics 2014, 109:240-244.
45. Croft N.P., de Verteuil D.A., Smith S.A., Wong Y.C., Schittenhelm R.B., Tscharke D.C., Purcell A.W. Simultaneous quantification of viral antigen expression kinetics using data-independent (DIA) mass spectrometry. Mol Cell Proteomics 2015, 14:1361-1372.
46. Hopfgartner G., Tonoli D., Varesio E. High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal Bioanal Chem 2012, 402:2587-2596.
47. Gillet L.C., Navarro P., Tate S., Rost H., Selevsek N., Reiter L., Bonner R., Aebersold R. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 2012, 11. p. O111.016717.
48. Caron E., Kowalewski D.J., Chiek Koh C., Sturm T., Schuster H., Aebersold R. Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry. Mol Cell Proteomics 2015, 14:3105-3117.
49. Caron E., Espona L., Kowalewski D.J., Schuster H., Ternette N., Alpizar A., Schittenhelm R.B., Ramarathinam S.H., Lindestam Arlehamn C.S., Chiek Koh C., et al. An open-source computational and data resource to analyze digital maps of immunopeptidomes. Elife 2015, 4.
50. Admon A., Bassani-Sternberg M. The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing. Mol Cell Proteomics 2011, 10. p. O111.011833.
51. Caron E., Vincent K., Fortier M.H., Laverdure J.P., Bramoulle A., Hardy M.P., Voisin G., Roux P.P., Lemieux S., Thibault P., et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 2011, 7:533.
52. Robinson S.D., Safavi-Hemami H., Raghuraman S., Imperial J.S., Papenfuss A.T., Teichert R.W., Purcell A.W., Olivera B.M., Norton R.S. Discovery by proteogenomics and characterization of an RF-amide neuropeptide from cone snail venom. J Proteomics 2015, 114:38-47.
53. Granados D.P., Laumont C.M., Thibault P., Perreault C. The nature of self for T cells - a systems-level perspective. Curr Opin Immunol 2015, 34:1-8.
54. Dalet A., Vigneron N., Stroobant V., Hanada K., Van den Eynde B.J. Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5. J Immunol 2010, 184:3016-3024.
55. Dalet A., Robbins P.F., Stroobant V., Vigneron N., Li Y.F., El-Gamil M., Hanada K., Yang J.C., Rosenberg S.A., Van den Eynde B.J. An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc Natl Acad Sci U S A 2011, 108:E323-E331.
56. Michaux A., Larrieu P., Stroobant V., Fonteneau J.F., Jotereau F., Van den Eynde B.J., Moreau-Aubry A., Vigneron N. A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming. J Immunol 2014, 192:1962-1971.
57. Berkers C.R., de Jong A., Schuurman K.G., Linnemann C., Geenevasen J.A., Schumacher T.N., Rodenko B., Ovaa H. Peptide splicing in the proteasome creates a novel type of antigen with an isopeptide linkage. J Immunol 2015, 195:4075-4084.
58. Berkers C.R., de Jong A., Schuurman K.G., Linnemann C., Meiring H.D., Janssen L., Neefjes J.J., Schumacher T.N., Rodenko B., Ovaa H. Definition of proteasomal peptide splicing rules for high-efficiency spliced peptide presentation by MHC class I molecules. J Immunol 2015, 195:4085-4095.
59. Delong T., Wiles T.A., Baker R.L., Bradley B., Barbour G., Reisdorph R., Armstrong M., Powell R.L., Reisdorph N., Kumar N., et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 2016, 351:711-714.